Darryl R. Davis

Implantable cardioverter defibrillators: therapy against Canada's leading killer.

Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.

Appropriate result from an inappropriate ICD shock.

Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death.

Successful ablation of a concealed parahisian accessory pathway using a remote magnetic navigation system following failure by conventional methods.

Transient left ventricular apical ballooning following a prolonged ablation.

Acute reversible left ventricular dysfunction secondary to alcohol.

Remote magnetic navigation-assisted catheter ablation enhances catheter stability and ablation success with lower catheter temperatures.

Ventricular tachycardia following tube thoracotomy.

Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Autologous cell therapy for cardiac repair.

Posterior his bundle electrogram location in a patient with atrioventricular nodal reentrant tachycardia and structurally normal heart.

Superior vena cava obstruction due to pacemaker leads.

Selectins for cardiosphere culture: the "E's" have it!

Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium.

The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function.

The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium.

Activation of GATA4 gene expression at the early stage of cardiac specification.

Resident cardiac stem cells and their role in stem cell therapies for myocardial repair.

Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity.

Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.

Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe?

Paracrine Engineering of Human Explant-Derived Cardiac Stem Cells to Over-Express Stromal-Cell Derived Factor 1α Enhances Myocardial Repair.

The impact of patient co-morbidities on the regenerative capacity of cardiac explant-derived stem cells.

Isolation of human explant derived cardiac stem cells from cryopreserved heart tissue.

Induced Pluripotent Stem Cell-Based Treatment of Acquired Heart Block: The Battle for Tomorrow Has Begun!

Cellular mechanisms underlying cardiac engraftment of stem cells.

The Frustration and Futility of Intracoronary Stem Cell Therapy.

Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.

Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.

Deterministic Encapsulation of Human Cardiac Stem Cells in Variable Composition Nanoporous Gel Cocoons To Enhance Therapeutic Repair of Injured Myocardium.

Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants.

Year in Review in Cardiac Electrophysiology.

Concise Review: Heart-Derived Cell Therapy 2.0: Paracrine Strategies to Increase Therapeutic Repair of Injured Myocardium.

Nanoengineered Electroconductive Collagen-Based Cardiac Patch for Infarcted Myocardium Repair.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells.

Year in Review in Cardiac Electrophysiology.

Systematic review of biological therapies for atrial fibrillation.

Cardiac stem cells in the post-Anversa era.

Immortalized factories of therapeutic vesicles.

Glyoxalase 1 Prevents Chronic Hyperglycemia Induced Heart-Explant Derived Cell Dysfunction.

A Strategy of Lead Abandonment in a Large Cohort of Patients With Sprint Fidelis Leads.

Paracrine Heart Repair Comes of Age.

A new electrocardiographic definition of left bundle branch block (LBBB) in patients after transcatheter aortic valve replacement (TAVR).

Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium.

The Cell Engraftment Hypothesis of Cardiac Repair.

Disease Modelling and Precision Medicine Using Canadian Cardiomyocytes.

Deterministic paracrine repair of injured myocardium using microfluidic-based cocooning of heart explant-derived cells.

Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction.

The Clinical Utility of Continuous QT Interval Monitoring in Patients Admitted With COVID-19 Compared With Standard of Care: A Prospective Cohort Study.

Systematic review of pre-clinical therapies for post-operative atrial fibrillation.

Collagen-Based Microcapsules As Therapeutic Materials for Stem Cell Therapies in Infarcted Myocardium.

High-power, short-duration atrial fibrillation ablation compared with a conventional approach: Outcomes and reconnection patterns.

High-power short-duration radiofrequency ablation of typical atrial flutter.

Electrophysiological engineering of heart-derived cells with calcium-dependent potassium channels improves cell therapy efficacy for cardioprotection.

State-of-play for cellular therapies in cardiac repair and regeneration.

Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction.

Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.

Nanoengineered Sprayable Therapy for Treating Myocardial Infarction.

Cell therapy for patients with Duchenne muscular dystrophy.

Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation.

Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side?

Correction to: Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation.